ArgentysBio is a pre-seed stage startup company created with the mission to accelerate the antibody development by making AI-augmented tools accessible and easy-to-use by researchers, to shorten the antibody development cycle from months and years to days. Our vision is to deliver a computation platform powered by agentic AI, enabling academic groups and companies of all sizes to develop innovative reagents and therapies.